Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-03

Study Completion Date

2025-05-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cerebral Palsy (CP) is the first cause of motor disability in children worldwide. ATLAS 2030 is a robotic gait exoskeleton designed to rehabilitate children with motor disability. The objective of this study is to analyse the efficacy of a training program with ATLAS 2023 in chilren with CP.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy

NCT05551364

Cerebral Palsy

COMPLETED NA

Impact of the Atlas 2030 Pediatric Exoskeleton on Gait Functionality and Quality of Life in Children With Cerebral Palsy or Related Conditions

NCT07066956

Cerebral Palsy Infantile

COMPLETED

Rehabilitative Effect of the Use of a Gait Exoskeleton in Patients With Neuromuscular Disease or Cerebral Palsy

NCT04813601

Neuromuscular Diseases Cerebral Palsy SMA II

COMPLETED NA

Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular Diseases

NCT04837157

Cerebral Palsy SMA II Neuromuscular Diseases

COMPLETED NA

Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury

NCT06772077

Spinal Cord Injury (SCI)

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A sample of children with CP will be divided into 2 groups, the experimental group will receive 32 sesions withe the ATLAS 2030 exoskeleton, whereas the control group will continue to receive their regular conventional therapy. Assessments will be performed at the beginning and the end of the intervention, as well as after 6, 9 and 12 months of the end of the intervention for follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exoskeleton group

sessions of rehabilitation with the ATLAS 2030 exoskeleton twice per week as part of their of their routine rehabilitation

ATLAS 2030

Intervention Type DEVICE

sessions of rehabilitation with the ATLAS 2030 exoskeleton twice per week as part of their routine rehabilitation

Control group

The children included in the control group will continue receiving their usual conventional therapy

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ATLAS 2030

sessions of rehabilitation with the ATLAS 2030 exoskeleton twice per week as part of their routine rehabilitation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medical authorization for standing, gait training and weight bearing.
* Informed consent signed by legal guardians.
* Confirmed diagnosis of cerebral palsy GMFCS levels III or IV.
* Proper family acceptance and commitment level.
* Receiving a minimum of 2 hours of therapy/activities promoting physical activity.
* Maximum user weight of 35 kg.
* Hip width (between greater trochanteres) less than or equal to 35 cm.
* Length of the thigh (distance from the greater trochanter to the lateral condyle of the tibia) from 24cm to 33cm.
* Tibia leg length (distance from the lateral condyle of the tibia to the lateral malleolus) from 23cm to 32cm.
* Shoe size 27-33 (EU)

Exclusion Criteria

* More than 8 sessions of robotic therapy during a month in the previous year to the beginning of the study.
* Intensive rehabilitation during the study.
* Imposibility of the family to fulfill treatment calendar.
* Spasticity equal to 4 on the Modified Ashworth Scale at the time of use of the device.
* More than 20º of hip and/or knee flessum at the time of using the exoskeleton.
* Necessity to walk with 10º of hip abduction.
* Necessity to walk with more than 9º of ankle dorsiflexion or plantar flexion or impossibility to use an orthosis to reach 90º in the ankle joint.
* Severe skin lesion on parts of the lower extremities that are in contact with the device.
* Scheduled surgery (rachis, limbs) for the duration of the study or surgery performed (rachis, extremities) in the last 6 months.
* History of fracture without trauma. History of bone fracture traumatic in lower extremities or pelvic girdle in the last 3 months.
* Severe rigid orthopedic deformities of the spine and/or lower limbs.
* Cognitive or conductual disorders that may lead to a lack of adherence to the attachment to the device.
* Conditions that provoke exercise intolerance.
* Conductual disorders that may interfere with the use of the device or their participation in the study, like impulsiveness or the inability to understand simple comands.
* Allergy to any of the ATLAS materials: cotton, nylon, polyester, polyamide, polyethylene or propylene.

Minimum Eligible Age

3 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No